Medscape Hematology-Oncology Headlines

ASCO 2008: Breast Cancer

Thu, 24 Jul 2008 12:00:00 EDT

Noteworthy presentations at ASCO 2008 focused on targeted therapies and adjuvant chemotherapy strategies.
Medscape Hematology-Oncology

Barrett Esophagus: Prevalence of Central Adiposity, Metabolic Syndrome, and a Proinflammatory State

Thu, 24 Jul 2008 12:00:00 EDT

Metabolic syndrome is a highly prevalent condition that may have important implications in the development of esophageal cancer. The current study examines this syndrome among patients with Barrett's esophagus.
Annals of Surgery

Everolimus Potential Alternative for Metastatic Renal Cell Carcinoma

Thu, 24 Jul 2008 08:49:20 EDT

The mammalian target of rapamycin might prolong progression-free survival in patients who have already tried other targeted therapies.
Medscape Medical News

Targeted Therapy for Breast Cancer

Thu, 24 Jul 2008 12:02:24 EDT

In this report from ASCO 2008, Dr. Harold Burstein reviews the AVADO results and other intriguing findings related to the use of targeted therapies for breast cancer.
Medscape Hematology-Oncology

Advances in the Treatment of Early Stage Breast Cancer

Thu, 24 Jul 2008 12:02:24 EDT

Data from studies reported at ASCO 2008 may help clinicians fine tune adjuvant regimens for patients with early- stage breast cancer.
Medscape Hematology-Oncology

Sorafenib Increases Survival in Advanced Liver Cancer

Thu, 24 Jul 2008 17:00:00 EDT

The multikinase inhibitor sorafenib significantly extended overall survival in patients with advanced hepatocellular carcinoma and also increased the median time to radiologic progression.
Medscape Medical News

ASCO 2008: Genitourinary Cancer

Wed, 23 Jul 2008 12:00:00 EDT

Important new data about drug treatment of renal and prostate cancers, as reported at ASCO 2008, are highlighted by experts.
Medscape Hematology-Oncology

Advances in the Treatment of Renal Cell Carcinoma

Wed, 23 Jul 2008 15:09:14 EDT

Several important advances in targeted and other therapies for renal cell carcinoma are reviewed in this report from ASCO 2008.
Medscape Hematology-Oncology

What's New in the Treatment of Prostate Cancer? Updates From ASCO 2008

Wed, 23 Jul 2008 15:09:14 EDT

In this conference summary, Dr. Joshi Alumkal looks at the latest data presented at ASCO 2008 in the area of advanced prostate cancer.
Medscape Hematology-Oncology

ASCO 2008: Lung and Head/Neck Cancer

Tue, 22 Jul 2008 12:00:00 EDT

Read these summaries to keep up with the latest data from ASCO 2008 on the treatment of lung and head/neck cancers.
Medscape Hematology-Oncology

Novel Vaccine Boosts Survival in Glioblastoma Patients

Tue, 22 Jul 2008 09:12:00 EDT

A dendritic cell vaccine significantly increased time to survival and time to tumor progression in glioblastoma patients, and a correlation was shown between cancer clinical outcome and T cell responsiveness after therapeutic vaccination.
Medscape Medical News

Vytorin Misses Primary End Point in SEAS Study

Tue, 22 Jul 2008 11:12:00 EDT

The combination of ezetimibe and simvastatin was no better than placebo in reducing the primary composite end point of aortic-valve and cardiovascular events but was significantly more effective in reducing the risk of ischemic events, a secondary composite end point. An increased cancer risk, however, got everybody's attention, although investigators and outside experts do not believe the hazard to be real.
Heartwire

Highlights in Lung Cancer

Tue, 22 Jul 2008 15:20:38 EDT

This summary reviews the latest data from ASCO 2008 on the treatment of lung cancer.
Medscape Hematology-Oncology

Highlights in Head and Neck Cancer

Tue, 22 Jul 2008 15:20:39 EDT

This summary reviews the latest data from ASCO 2008 on the treatment of head and neck cancer.
Medscape Hematology-Oncology

Breast Examination May Not Improve Breast Cancer Survival

Tue, 22 Jul 2008 17:00:00 EDT

According to a Cochrane review, breast cancer self-examination or physical examination does not improve breast cancer survival and may increase biopsies of benign lumps.
Medscape Medical News

FDA Approves Genetic Test for Patients With Breast Cancer

Tue, 22 Jul 2008 17:47:00 EDT

This novel genetic test, SPOT-Light HER2 CISH, should help predict the response of patients with breast cancer to trastuzumab treatment.
Medscape Medical News

Combination of Gene Expression Data With Clinical Data Best Predicts Survival in Lung Adenocarcinoma

Tue, 22 Jul 2008 17:55:33 EDT

A large study found that hazard ratios for predictive models of early-stage lung cancer increase when clinical data are included.
Medscape Medical News

Physicians for Sale: How Medical Professional Organizations Exploit Their Members

Mon, 21 Jul 2008 08:50:07 EDT

To improve the state of US healthcare, physicians need to rethink what their profession is and identify what they need to do to regain their professional integrity.
The Medscape Journal of Medicine

From AGS 2008: Ethics and Quality of Life in the Elderly: Recent Advances

Mon, 21 Jul 2008 16:20:49 EDT

A report on framing informed consent decisions in individuals with early dementia and the impact of depressive symptoms on quality of life.
Medscape Internal Medicine

Pathologists Respond to Criticism After Breast Cancer Testing Errors

Sat, 19 Jul 2008 11:45:46 EDT

Experts say staffing and funding constraints made the blunders more likely and oncologists must remain vigilant and verify test results.
Medscape Medical News